InvestorsObserver
×
News Home

Organovo Holdings Inc (ONVO) Stock: What Does the Chart Say Tuesday?

Tuesday, November 07, 2023 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Organovo Holdings Inc (ONVO) Stock: What Does the Chart Say Tuesday?

Organovo Holdings Inc (ONVO) stock has gained 63.21% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Organovo Holdings Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ONVO!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ONVO Stock Today?

Organovo Holdings Inc (ONVO) stock is trading at $1.73 as of 10:38 AM on Tuesday, Nov 7, a rise of $0.31, or 21.83% from the previous closing price of $1.42. The stock has traded between $1.39 and $1.84 so far today. Volume today is high. So far 532,157 shares have traded compared to average volume of 43,422 shares.

More About Organovo Holdings Inc

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels. Click Here to get the full Stock Report for Organovo Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App